Page last updated: 2024-10-30

mebendazole and Puerperal Disorders

mebendazole has been researched along with Puerperal Disorders in 2 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moliner, JV1
Valverde, AG1
Sorolla, JM1
Kurzel, RB1
Toot, PJ1
Lambert, LV1
Mihelcic, AS1

Other Studies

2 other studies available for mebendazole and Puerperal Disorders

ArticleYear
[Loa loa meningoencephalitis secondary to treatment with mebendazol].
    Medicina clinica, 2011, Feb-26, Volume: 136, Issue:5

    Topics: Adolescent; Albendazole; Animals; Anthelmintics; Brain Damage, Chronic; Central Nervous System Helmi

2011
Mebendazole and postpartum lactation.
    The New Zealand medical journal, 1994, Oct-26, Volume: 107, Issue:988

    Topics: Ancylostomiasis; Ascariasis; Female; Helminthiasis; Humans; Lactation; Mebendazole; Postpartum Perio

1994